JPS6193121A - 抗腫瘍免疫細胞誘導材 - Google Patents

抗腫瘍免疫細胞誘導材

Info

Publication number
JPS6193121A
JPS6193121A JP59214326A JP21432684A JPS6193121A JP S6193121 A JPS6193121 A JP S6193121A JP 59214326 A JP59214326 A JP 59214326A JP 21432684 A JP21432684 A JP 21432684A JP S6193121 A JPS6193121 A JP S6193121A
Authority
JP
Japan
Prior art keywords
cells
leukocytes
tumor
oligosaccharide
activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP59214326A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0362700B2 (enrdf_load_stackoverflow
Inventor
Hideji Kaieda
海江田　豪児
Kimimasa Yamada
山田　公政
Naokuni Yamawaki
山脇　直邦
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd filed Critical Asahi Chemical Industry Co Ltd
Priority to JP59214326A priority Critical patent/JPS6193121A/ja
Priority to DE8484114813T priority patent/DE3483252D1/de
Priority to EP84114813A priority patent/EP0147689B1/en
Publication of JPS6193121A publication Critical patent/JPS6193121A/ja
Priority to US07/096,259 priority patent/US4839290A/en
Publication of JPH0362700B2 publication Critical patent/JPH0362700B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP59214326A 1983-12-05 1984-10-15 抗腫瘍免疫細胞誘導材 Granted JPS6193121A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP59214326A JPS6193121A (ja) 1984-10-15 1984-10-15 抗腫瘍免疫細胞誘導材
DE8484114813T DE3483252D1 (de) 1983-12-05 1984-12-05 Verfahren zur induktion von antitumorimmunozyten, verfahren zur herstellung von antitumorimmunozyten und durch das verfahren hergestellte antitumorimmunozyten.
EP84114813A EP0147689B1 (en) 1983-12-05 1984-12-05 A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
US07/096,259 US4839290A (en) 1983-12-05 1987-09-08 Process for producing cytotoxic T-cells and compositions produced by said process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59214326A JPS6193121A (ja) 1984-10-15 1984-10-15 抗腫瘍免疫細胞誘導材

Publications (2)

Publication Number Publication Date
JPS6193121A true JPS6193121A (ja) 1986-05-12
JPH0362700B2 JPH0362700B2 (enrdf_load_stackoverflow) 1991-09-26

Family

ID=16653899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59214326A Granted JPS6193121A (ja) 1983-12-05 1984-10-15 抗腫瘍免疫細胞誘導材

Country Status (1)

Country Link
JP (1) JPS6193121A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
JPH0362700B2 (enrdf_load_stackoverflow) 1991-09-26

Similar Documents

Publication Publication Date Title
Selmaj et al. Anti—tumor necrosis factor therapy abrogates autoimmune demyelination
EP0147689B1 (en) A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
JP2618497B2 (ja) 腫瘍障害細胞誘導剤および腫瘍障害細胞誘導デバイス
JPS61277628A (ja) 癌治療用白血球刺激材
JPS6193121A (ja) 抗腫瘍免疫細胞誘導材
JPS61280432A (ja) 抗腫瘍免疫細胞誘導方法
JPH0466210B2 (enrdf_load_stackoverflow)
JPH0556360B2 (enrdf_load_stackoverflow)
JPS63160578A (ja) 抗腫瘍キラ−ｔ細胞の誘導方法
JP2005102656A (ja) 細胞培養器具およびそれを用いた細胞製剤の製造方法
JPS6193122A (ja) 刺激剤混入のない悪性腫瘍治療用活性化免疫細胞
JPH0586929B2 (enrdf_load_stackoverflow)
JP3620863B2 (ja) インターロイキン１の産生誘導方法
JPS6229524A (ja) 悪性腫瘍治療用刺激剤
RU2109522C1 (ru) Способ получения магнитоуправляемого композита для биомедицинских целей
Roffman et al. Chemical reduction of oxidized human lymphocytes inhibits interleukin 2 production but not induction of interleukin 2 responsiveness.
JPH0362699B2 (enrdf_load_stackoverflow)
JPH11127851A (ja) 抗原特異的免疫抑制性細胞の誘導増殖方法およびこれに用いる培養器具
LAUSE et al. INTERACTION OF PLASMA FIBRONECTIN IN THE IN VITRO ALLOGRAFT RESPONSE1
Higgins Duck lymphocytes. VI. Requirement for phagocytic and adherent cells in lymphocyte transformation
JP2834514B2 (ja) 血液細胞処理剤
JPS5978122A (ja) コロニ−刺激因子の製造法
US5093479A (en) Regulatory glycoprotein for immune response and the use, thereof in the production of t-cell growth factor
JPH1067681A (ja) 癌ワクチン及びその製造法
Rella et al. MLC-activation by acute lymphatic leukemia blasts